Figure 1.
Figure 1. Efficient engraftment and complete reconstitution of human lymphocytes in NOD/SCID/γcnull mice that underwent transplantation with CB CD34+ cells. 1 × 104 (n = 7) or 5 × 104 (n = 17) CB CD34+ cells were transplanted into NOD/SCID/γcnull mice, and 1 × 105 (n = 15) CB CD34+ cells were transplanted into NOD/SCID mice. (A) Percentages of human CD45+cells in PB of mice were analyzed 3 months after transplantation using flow cytometry. Percentages of human CD45+cells were calculated as: % human CD45+ = human CD45+cells/(human CD45+cells +mouse CD45+cells) × 100. Results of 7 independent experiments are shown. (B) Representative FACS analysis of human lymphocytes in BM and spleen of NOD/SCID/γcnull mice that underwent transplantation with CB CD34+ cells. (C) Representative FACS analysis of KIR antigens is shown. CD158a or KIR p70 were detected on 7.7% or 3.8% of CD56+cells, respectively.

Efficient engraftment and complete reconstitution of human lymphocytes in NOD/SCID/γcnull mice that underwent transplantation with CB CD34+ cells. 1 × 104 (n = 7) or 5 × 104 (n = 17) CB CD34+ cells were transplanted into NOD/SCID/γcnull mice, and 1 × 105 (n = 15) CB CD34+ cells were transplanted into NOD/SCID mice. (A) Percentages of human CD45+cells in PB of mice were analyzed 3 months after transplantation using flow cytometry. Percentages of human CD45+cells were calculated as: % human CD45+ = human CD45+cells/(human CD45+cells +mouse CD45+cells) × 100. Results of 7 independent experiments are shown. (B) Representative FACS analysis of human lymphocytes in BM and spleen of NOD/SCID/γcnull mice that underwent transplantation with CB CD34+ cells. (C) Representative FACS analysis of KIR antigens is shown. CD158a or KIR p70 were detected on 7.7% or 3.8% of CD56+cells, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal